Mia's Feed
Medical News & Research

Genetic Inheritance and Parental Influence Play Key Role in Childhood Obesity

Genetic Inheritance and Parental Influence Play Key Role in Childhood Obesity

Share this article

New research highlights the genetic and environmental influences of parents on their children's risk of obesity, emphasizing the dual role of inherited genes and maternal impact during adolescence.

1 min read

Recent research reveals that children of obese parents are at a higher risk of developing obesity themselves. This increased risk is largely attributed to the inheritance of obesity-related genes, which significantly influence a child's weight. Interestingly, the study also highlights a smaller but notable impact of indirect genetic effects from mothers—those genes that affect the child's environment but are not directly inherited. These nurture effects appear most influential during adolescence. The findings suggest that maternal BMI has a dual impact on children's weight, both through inherited genetic factors and environmental influences, while paternal influence remains primarily linked to directly inherited genes. The research underscores the importance of considering genetic and environmental factors together when addressing childhood obesity. Policy measures aimed at reducing obesity could therefore benefit future generations by focusing on parental health and family-based interventions.

This study was led by Liam Wright from University College London and published in PLOS Genetics. It involved analyzing genetic and BMI data from over 2,500 parent-child trios, providing insight into how inherited genetics and parental influence contribute to childhood obesity.

Source: https://medicalxpress.com/news/2025-08-kids-obese-parents-obesity-due.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Lecanemab: A Well-Tolerated Treatment for Early-Stage Alzheimer's Disease in Real-World Settings

Recent studies indicate that lecanemab, an Alzheimer's drug, is safe and well tolerated outside clinical trials, especially when administered in specialized outpatient clinics. The treatment can slow disease progression with minimal risk of severe side effects, particularly in patients with early-stage Alzheimer's.

Majority of Patients with Advanced Melanoma Remain Disease-Free Four Years Post-Neoadjuvant Immunotherapy

A groundbreaking study shows that nearly 87% of advanced melanoma patients remain disease-free four years after pre-surgical immunotherapy, highlighting the potential of neoadjuvant treatment to improve long-term outcomes.

The Nose-Brain Link: How Smelling Food Influences Hunger and Fullness

New research reveals a direct neural pathway from the nose to the brain that influences feelings of fullness, opening potential for innovative obesity treatments.

Innovative Approach Reduces Stroke Risk in Heart Failure Patients with LVADs

New research utilizing blood flow modeling offers promising strategies to reduce stroke risk in patients with LVADs, improving the safety and personalization of heart failure treatments.